More than 80% CRC tumors carry inactivating mutations in the regulatory component of Wnt pathway such as the APC. APC have been implemented to be a decisive factor in the malignant transformation of the CRC epithelial cells [7]. This evidence concerns the gene APC and colorectal carcinoma.